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Homology modelling is one of the important alternative techniques to X-
ray crystallography and nuclear magnetic resonance (NMR) spectroscopy 
in structural determination of protein. CYP2D6 drug metabolizing 
enzymes have extensively studied prior to the successful determination of 
its 3D structure using X-ray crystallography. This study is one of the 
earlier works being carried out before the crystal structure was solved. 
The enzyme is polymorphic and more than 80 different alleles have been 
identified.  The aim of this study is to identify possible criteria to 
improve the quality of 2D6 model. Four mammalian crystal structures 
CYP2C8, CYP2B4, CYP2C9 and CYP2C5 were selected from protein 
databank as template for CYP2D6 model. Multiple sequence alignment 
between the selected target and template was performed. Secondary 
structure prediction was generated using CYP2D6 sequence and the 3D 
models built based on each template. The quality of the models was 
evaluated using Ramachandran’s plot. The final models were 
superimposed with CYP2D6 crystal structure. The result shows that not 
only the sequence identity is important for the template selection but also 
the alignment length of sequence. The secondary structure prediction of 
CYP2D6 sequence was found significantly matched the secondary 
structure prediction of the 3D structures of CYP2D6 models. The 
stereochemical quality of CYP2D6 models were found adequately 
satisfied the Ramachandran.plot requirements and comparable to the 
stereochemical quality crystal structure proteins used as templates and 
CYP2D6 crystal structure.  The criteria set shows that CYP2C8 is the 
better template for homology modelling of CYP2D6 since it has scored 
lower E-value and longer alignment length, high sequence identity 
provided by ClustalW . In addition the secondary structure prediction of 
the model better matched the consensus and  satisfy the criteria of 
Ramachandran’s plot as well it retained lowest RMSD value from the 
crystal structure. The study concludes to that the length of the sequence 
alignment is a critical factor in template selection it is also shows the 
important primary and secondary structure prediction. 
Keywords: Homology modelling, CYP2D6, CYP2C8, CYP2C9, 
CYP2B4,  CYP2C5. 
 








Protein function is closely related to its structure. 
The structural determination of protein is one of 
the key steps in understanding molecular basis of 
protein function. X-ray crystallography and 
nuclear magnetic resonance (NMR) spectroscopy 
are the only two experimental techniques used to 
determine the protein three dimensional 
structures, (3D). However, these techniques are 
not suitable to be applied to some proteins. Most 
proteins have poor solubility or too large for X-
ray and NMR to solve the structure, respectively 
[1,2]. These two techniques are also laborious 
and time-consuming. As an alternative, many 
scientists have relied on computational protein 
structure prediction methods such as comparative 
modelling or homology modelling since this 
method is straightforward, fast and reliable [3].  
Homology modelling is indeed a well-known and 
important technique to predict the 3D structures 
of proteins  and have proven to be successful in 
the areas of pharmaceuticals as well as drug 
design and development [4,5].  The accuracy of 
this technique however, highly depends on the 
template selection, sequence alignment and the 
percentage of sequence identity between a target 
and a template protein [2,6].    
 
Cytochrome P450s  
Cytochrome P450s protein was firstly recognised 
in 1958 by Klingenberg Martin in a rat liver 
microsome’s suspension) [7].  Cytochrome P450s 
are intracellular genetic protein term for a super-
family (CYP's) consisting of heme-containing 
mono-oxygenases enzymes that catalyses 
oxidative metabolism of a wide variety of 
endogenous and exogenous compounds [8,9]. 
Cytochrome P450 2D6 (CYP2D6) is one of the 
most important drug metabolizing enzymes in 
this family. It is responsible for the metabolism of 
20-30% of therapeutically used drugs [1,10,11]. 
The enzyme is highly polymorphic in nature and 
more than 80 different alleles have been 
identified [8,10]. Prior to the successful 
determination of its 3D structure using X-ray 
crystallography in 2006, [12] a lot of work was 
carried out in predicting the 3D structure of 
CYP2D6 using  the method of homology 
modelling [13-15].  And this study was one of the 
earlier works being carried out before the crystal 
structure was solved.  
 
The aim of this study was to evaluate the quality 
of the CYP2D6 models based of mammalian 
crystal structures with respect to the sequence 
identity, secondary structure prediction, 
streochemical quality and RMSD from CYP2D6 
crystal in order to investigate possible criteria to 
improve the quality of the predicted models.  
 
Methods 
Primary structure prediction:  
The sequence of CYP2D6 was obtained from 
SwissProt database [16] with the primary 
accession number of P10635 (497 amino acid 
residues). All protein sequences related to the 
CYP2D6 sequence were identified using pairwise 
sequence alignment PSI-BLAST [17]. From the 
PSI- BLAST search result, four mammalian 
crystal structures sequences were selected as the 
templates. They were human CYP2C9, (PDBID 
1OG2) [18], human CYP2C8, (PDBID 1PQ2) 
[19], rabbit CYP2C5, (PDBID 1DT6) [20] and 
another rabbit enzyme CYP2B4, (PDBID 1PO5) 
[21].  
 
Multiple sequence alignment between the target 
CYP2D6 and all the templates was generated 
with using CLUSTALW [22] .The CYP2D6 
primary sequence was also analysed to predict 
transemembrane helices regions using Hidden 
Markov Models (TMHMM) [23] . 
 
Secondary structure prediction 
The secondary structures of CYP2D6 was 
predicted using the programme PROF [24],  
PSIPRED [25] and FI-Pred [26].  A consensus of 
predicted secondary structures was manually 
done based on the results obtained from these 
programmes. 
 




Four models of CYP2D6 were built using 
MODELLER 6 version 2 [27-30] with each 
model developed based on the templates 
CYP2C8, CYP2C9, CYP2C5 and CYP2B4. The 
stereochemistry of the models were checked 
using the programme PROCHECK [31].  The 
model that better satisfied the Ramachandran plot 
was selected as the raw model of CYP2D6 for 
further evaluation and optimization. The 
optimization was carried out using the 
MODELLER’s loop refinement protocol in order 
to optimise the amino acid residues which are 
located in the disallowed regions of the 
Ramachandran plot. The secondary structure 
determination was performed using the 
programme STRIDE [32] which were then 
compared to the consensus of the predicted 
secondary structures. Finally, the CYP2D6 
crystal structure (PDBID 2F9Q) [12] was used as 
a marker to evaluate the accuracy of the refined 
models based on the C-alpha RMSD.  
 
Results and discussion  
Sequence identity search results 
From the results of PSI-BLAST, four mammalian 
proteins were selected as the possible templates 
for CYP2D6 as shown in Table 1. The results 
show that CYP2C8 has 362 hit score compared to 
CYP2B4, CYP2C9 and CYP2C5 which have the 
scores of 354, 339 and 338, respectively. This 
score is a scale of conservation obtained from the 
sequence alignment between the target and the 
possible template sequences.  For each position in 
the derived scale, each residue assigns a score. 
For highly conserved residue at a particular 
position, will give a high positive score while at 
weakly conserved or unconserved position will 
give lower scores (near zero) [22]. 
 
The results also show that the all the sequence 
identities between CYP2D6 and all the templates 
(CYP2B4, CYP2C5, CYP2C8 and CYP2C9) are 
above 40% (Table1).  The enzyme CYP2B4 
shared the highest sequence identity (44%) with 
CYP2D6 sequence but shorter sequence 
alignment length. The alignment length of 
CYP2B4 is 440 amino acid residues, 196 of the 
amino acids are identical to CYP2D6 sequence. 
The second highest sequence identity is CYP2C5 
with 42% sequence identity with alignment 
length of  469 amino acid residues. 197 of these 
residues were identical with CYP2D6 sequence. 
It is also shown that human CYP2C9 shared 40% 
sequence identity with CYP2D6 sequence with 
alignment length of 477 amino acid residues and 
193 of the total amino acids were identical with 
CYP2D6 sequence. The last template which is 
CYP2C8 showed the sequence identity, 41% with 
alignment length of 205 amino acids. CYP2C8 
showed the longest alignment length compared to 
CYP2B4, CYP2C5 and CYP2C9 sequences 
despite its lowest percentage of sequence identity. 
This result indicates that the percentage of 
sequence identity decreases with the increase in 
alignment length and was consistent with the 
findings from previous study [33] .  
 
PSI-BLAST programme compares both the 
sequence identity and the alignment length using 
expectation value (E-value) [17]. The smaller the 
E-value the most identical the sequences are. The 
E-values obtained were almost zero (significant) 
as shown in Table 1. The results show high 
sequence similarity between all the templates and 
the CYP2D6 enzyme. It is also shown that 
CYP2C8 has lower E-value followed by 
CYP2B4, CYP2C9 and CYP2C5. Therefore, all 
the templates have E values low enough proving 
that the match did not occur by chance[17].  
Thus, it could be concluded that these four 
templates satisfy the criteria for best template 
selection [33,34]  and according to Sánchez and 
Šali (1997), accurate model can be built  from 
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Table 1 PSI-BLAST search results. 








Human CYP2D6 (target) 497 497 969 (497/497) = 100 0.0 
Human CYP2C8  CYPIIC8)  
(template) 490 495 362 (205/495) = 41.0 e
-99 
Rabbit CYP2B4 (template) 491 440 354 (196/440) = 44.0 3e-97 
Human CYP2C9  (CYPIIC9) 
(template) 490 477 339 (193/477) = 40.0 8e
-93 
Rabbit CYP2C5 (template) 487 469 338 (197/469) = 42.0 2e-92 
 
Table 2. Multiple sequence alignment scores obtained by CLUSTALW. 
Protein name Chain length Alignment length ClustalW score 
Human CYP2D6   (target) 497 497 - 
Human CYP2C8  (CYPIIC8) (template)  490 476 41 
Rabbit CYP2B4   491 476 40 
Human CYP2C9  (CYPIIC9) 490 475 39 
Rabbit  CYP2C5   487 473 39 
 
 
The primary sequence analysis   
The multiple sequence alignment between 
CYP2D6, CYP2C8, CYP2C9, CYP2C5 and 
CYP2B4 proteins results have identified regions 
of similarities, conserved and unconserved 
regions. The statistical part of ClustalW results 
[22] was shown in Table 2. This result shows the 
consequence functional, structural, relationships 
between the CYP2D6 sequence and the selected 
template. The results also show that all the 
template sequences having more than 30% of 
sequence identity with the target sequence with 
CYP2C8 shared high sequence identity (41%) 
followed by CYP2B4 (40%), CYP2C9 and 
CYP2C5 which have the same sequence identity 
(39%). The results of sequence alignment differ 
slightly from PSI-BLAST results.   
The sequences of the crystal structures of the 
templates are edited prior model building.  It is 
found that the first 27 (1-27) amino acid residues 
of the crystal structure of CYP2C8 are missing. 
These missing residues correspond to the first 31 
(1-31) in the target sequence (CYP2D6).  
Therefore, the first 31 (1-31) amino acid residues 
of CYP2D6 sequence are deleted from CYP2D6 
sequence and the alignment started from the 
amino acid residue ARG 32. While the missing 
residue of CYP2B4 are the first 30 correspond to 
the first 30 amino acid residues of CYP2D6 
sequence which are also deleted and the model 
built based on CYP2B4 began from the amino 
acid residue ALA 31. Similarly, CYP2C9 and 
CYP2C5 lacks the first 29 (1-29) amino acid 
residues which correspond to the first 33 amino 
acids residues of CYP2D6 sequence and thus, the 
model built based on CYP2C5 began from amino 
acid PRO 34. In addition CYP2C5 crystal 
structure lacks other 10 residues from amino 
residue TYR 212 to LEU 222.  The published 
crystal structure of CYP2D6 starts from amino 
acid residue PRO 34. Hence, the first 33 amino 
acid residues are absent in the crystal structure 
templates and experimental crystal CYP2D6. 
These missing residues are transmembrane 
segment, as confirmed by the result of the 
primary sequence analysis obtained from the 
Hidden Markov Models (TMHMM) [23]  which 
show that the first 25 amino acid residues of 
CYP2D6 sequence are transmembrane protein 
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Figure 1: The TMHMM plot shows the predicted Transmembranes segments in CYP2D6 sequence, and the first segment 
was from 0 -25 amino acid residues Interpreted  by red bar  above the first highest peak. 
 
 
Secondary structure prediction 
The predicted transemembrane segment is further 
investigated using secondary structure prediction 
method. The secondary structures of CYP2D6 
predicted by PROF, PsiPred and FI-FRED 
methods were presented in Table 3. Almost all 
programmes agreed in the identification of this 
region as the transmembrane segment. The results 
of PROF, PsiPred and FI-FRED of secondary 
structure prediction for the whole CYP2D6 are 
shown in Table 4.  
           
 
Table 3. Secondary structure prediction of the first 25 amino acid residues using PROF, PsiPred and FI-Pred schemes. 
Amino acid N0. 1        2 3 4 5 6 7 8 9 1 0 11 12   13 
Amino acid M G L E A L V P L A V I V 
PROF C C C H H H H H H H H H H 
PsiPred C C H H H H H H H H H H H 
FI-Pred C C H H H H H H H H H H H 
Consensus C C H H H H H H H H H H H 
Amino acid S. N0. 14 15 16 17 18 19 20 21 22 23 24 25  
Amino acid A I F L L L V D L M H R  
PROF H H H H H H H H H H H C  
PsiPred H H H H H H H H H H H H  
FI-Pred H H H H H H H H H H H H  
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Table 4. Summary of secondary structure prediction results of CYP2D6 using PROF, PsiPred and FI-Pred schemes. 
Coil loops(C) Helixes(H) β-sheets(E) Scheme 
Freqequency  % age  Frequency   % age Frequency.   %age 
PROF 238 48.0 240 48.0 19 4.0 
PsiPred 187 37.6 273 44.9 37 7.5 
FI-Pred 215 43.0 236 48.0 46 9.0 
Consensus 214 43.0 243 49.0 40 8.0 
  
 
The results showed that PROF and FI-Pred 
almost agreed in predicting the coil regions and 
helices and mainly form the consensus.  It is also 
noticed that long helices are the most common 
and composed of 15 -21 amino acid residues. In 
addition, the loops are short and distributed in 
fewer regions. The short region of loops is the 
characteristic of high resolution structure since 
the amino acids form tight turns (loops) between 
membrane helices [35,36]. The beta sheet regions 
in this result are interrupting the short coil 
regions. The three programmes agreed on the 
approximate locations, lengths and positions of 
alpha helices and the loop regions, but slightly 
disagreed in predicting the positions and lengths 
of beta sheets.  
 
The secondary structure analysis of 3D models of 
CYP2D6 using STRIDE [32] is shown in Table 
5. From the result of STRIDE, it is noticed that 
the secondary structures of the models mostly 
disagreed with the consensus prediction in coil 
regions.  The percentage of the coils form the 
consensus predictions are higher than the 
STRIDE prediction. This might be due to the 
variations in predicting the location of secondary 
structures using sequence and the 3D structure of 
the model. This result (Table 5) is represent 
matched for all the models built based on the four 
templates shows that no significant variations to 
matched the consensus. Thus, the four templates 
are inspected for more investigation to select the 
best template for CYP2D6. 
 
 
Table 5 Summary of secondary structure prediction results of 3D structures CYP2D6 models based STRIDE server   
     compared to the consensus prediction based on CYP2D6 to its sequence. 
 Model Freq. of  (C) % of  (C) Freq. of  (H) % of (H) Freq. of (E) % of (E) % of consistent
Consensus 214 43.0 243 49.0 40 8.0 100 
Model 
(CYP2C8) 
139 29.8 215 46.1 25 5.4 81.3 
Model 
(CYP2B4) 
141 30.3 208 44.6 22 4.7 79.6 
Model 
(CYP2C9) 
145 31.1 220 47.2 9 1.9 80.2 
Model 
(CYP2C5) 





Mahdi et al. International Journal of Drug Delivery 3 (2011) 386-396 
 
Homology modelling results:  
The good stereochemistry properties is an 
indication of good comparative modelling 
method [37]. The overall quality of each model is 
evaluated in order to identify any unfavourable 
contacts between the amino acid residues.  The 
results of model evaluations were listed in Table 
6. The raw model of CYP2D6 built using the 
template CYP2C8 shows the highest 
stereochemical quality. The model shows that 
91.4% of its residues are located in the most 
favoured region or the core region compared to 
other models built using other templates. [38]. 
The result of streochemical quality of CYP2D6 
model based on CYP2C8 also shows that only 
one amino acid residue is found located in the 
disallowed region of the Ramachandran Plot. For 
the model built based on the template CYP2C9, 
there are around 89.8% of the residues in the core 
region and two amino acids residues are found 
located in the disallowed region. Similarly, for 
the models built based on CYP2B4 and CYP2C5, 
88.9% and 85.5% of their amino acid residues are 
found located in the core regions, respectively. In 
the model of CYP2D6 built based on CYP2C5 
there are five residues located in the disallowed 
region. The significantly lower stereochemical 
quality of CYP2D6 model built based on 
CYP2C5 might be due to the fact that CYP2C5 
lacked ten amino acid residues between TYR 212 
to LEU 222.  Thus, this might affect the 
stereochemical quality and structural geometry of 
the model while doing the optimization step. For 
model built based on CYP2B4, no amino acid 
residue are found located inside the disallowed 
region of the Ramachandran plot, therefore no 
regional loop optimization were carried to this 
model. 
 
The results of the loop refinement or optimisation 
step are shown in Table 6. The resulting models 
are referred to as the refined models. Subjection 
of the model built based on CYP2C5 to loop 
optimisation step did not significantly improved 
the stereochemical properties of the model as 
opposed to the models built based on CYP2C8 
and CYP2C9. There is no change in the 
percentage of the amino acid residues in the core 
regions. The results of loop refinement of 
CYP2D6 model built based on CYP2C5 only 
pushed the amino acid residues in the disallowed 
region to the direction of allowed and generously 
allowed regions.  
 
Table 6 The detailed scores of assessed stereochemical quality for CYP2D6 models built based on the selected templates 
using PROCHECK [31].  
Template/CYP2D6  model/CYP2D6 









Human CYP2C8 experimental 
CYP2D6 (raw model) 
CYP2D6 (refined model) 

















Human CYP2C9 experimental 
CYP2D6 (raw model) 
CYP2D6 (refined model) 

















Rabbit CYP2B4 experimental 
CYP2D6 (raw model) 
CYP2D6 (refined model) 

















Rabbit CYP2C5 experimental 
CYP2D6 (raw model) 
CYP2D6 (refined model) 
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It is interesting that the stereochemical quality of 
the refined models (Table 6.) are significantly 
better compared to the stereochemical quality of 
the crystal structure templates listed in Table 1. It 
is also found that the results of stereochemical 
qualities of the refined models are better 
compared to the CYP2D6 experimental crystal 
structure as shown in Table 6. Consequently, the 
quality of the CYP2D6 model built based on 
human crystal structures CYP2C8 and CYP2C9 
are better compared to rabbit crystal structure 
CYP2B4 and CYP2C5. These results suggested 
that the human crystal structures are better 
templates for human CYP2D6 model compared 
to the rabbit crystal structures. Particularly, 
CYP2D6 model built based on the human 
CYP2C8 structure satisfied the stereochemical 
test better compared to CYP2D6 model based on 
CYP2C9 as shown by the backbone φ and ψ 
dihedral angles, of which 91.6% of the residues 
for the refined model located within the core 
regions, 7.3% with the allowed regions, 1% 
within generously allowed regions and no amino 
acid residue in the disallowed regions (Table 6). 
Despite the variation in the stereochemical 
quality built based on the selected templates, all 
models meet the requirements of good quality 
model based on the Ramachandran.plot [38] and 
the criteria of selection of good template for 
CYP2D6. Thus the selected templates are carried 
for further investigation to select best template 
for CYP2D6 model. 
 
Superimposed of CYP2D6 models with the 
CYP2D6 crystal structure  
The RMSD obtained from the superimposed of 
CYP2D6 models to it’s solved crystal structure 
(2F9Q) was shown in Table 7. CYP2D6 model 
built using template CYP2C8 showed RMSD of 
2.96 Å with respect to its crystal structure. Figure 
2 showed the schematic superimposed between 
the CYP2D6 model built based on CYP2C8 
template and the crystal structure. It is also shown 
in Figure 3 that the model developed shared high 
similarity with that of the crystal structure. This 
result suggested that the developed model is 
accurate.  Model built based on the template 
CYP2B4 shows highest RMSD value (6.39 Å) 
compared to other models. Based on all these 
findings, human CYP2C8 crystal structure is 
found to be an adequate template for model 
development of CYP2D6 since it satisfied all the 
criteria of best template selection in which it 
produced the most adequate and accurate model 
representing CYP2D6 compared to using other 
templates. It could be concluded that the 
alignment length played the most important role 
in accurately predicting the structure of CYP2D6. 




Table 7 RMSD analysis of CYP2D6 model from the crystal structure based on C alpha. 
 
Model of CYP2D6 RMSD (Å) 
Based on human CYP2C8 2.96 
Based on human CYP2C9 3.18 
Based on rabbit CYP2C5 3.44 
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Figure 2 Ribbon representations showing the superimposed of the model of CYP2D6 built based on CYP2C8 (yellow) to 
the crystal structure of CYP2D6 (blue). 
 
                                
             (a)                                 (b) 




As a conclusion, this study suggested that in 
order to accurately predict the 3D structure of 
proteins, not only the sequence identity and the 
accuracy of the sequence alignment are 
important, the length of the sequence alignment is 
also a critical factor in template selection for 
homology modelling. This study also showed the 
importance of the primary and the secondary  
 
structure predictions in homology modelling. It is 
also shown that the mammalian cytochrome P450 
sub family templates used in this study are 
evolutionary and structurally similar to CYP2D6. 
Particularly, human CYP2C8 and CYP2C9 which 
are more suitable than the rabbit CYP2C5 and 
finally human CYP2C8 is found to be the best 
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